Medical Equipment

Global Intranasal Drug Delivery Devices Market Trends and Growth Analysis 2025–2029

November 17, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Does The Market Size Of The Intranasal Drug Delivery Devices Industry Compare Between 2025 And 2029?

Significant expansion has characterized the market for intranasal drug delivery devices recently, projecting an increase from its $60.27 billion valuation in 2024 to $65.09 billion by 2025, reflecting a compound annual growth rate of 8.0%. This robust growth observed during the historical timeframe stems from several contributing factors, including the mounting prevalence of chronic respiratory ailments, heightened patient inclination and adherence to the delivery method, the ease associated with self-dosing, applications specifically designed for pediatric populations, the broadening scope within allergic rhinitis therapies, and an increasing spectrum of applicable conditions.

Anticipation is high for substantial expansion within the intranasal drug delivery devices sector in the coming years, projecting a market valuation reaching $91.05 billion by 2029, fueled by an annual growth rate of 8.8%. This upward trajectory throughout the prediction window is underpinned by several key factors, such as the growing elderly demographic, escalating worldwide prevalence of respiratory ailments, broadened utility in addressing neurological conditions, the shift toward tailored medical treatments, greater emphasis on proactive health measures, and market inroads in developing nations. Significant developments shaping this market during the forecast term involve progress in drug formulation techniques, concentrated efforts on suitability for children and the aged, augmentation in devices designed for personal use, the proliferation of nasal powder inhalers, and the integration of biological agents and peptide-based therapies.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13463&type=smp

Which Industry Drivers Are Expected To Accelerate The Intranasal Drug Delivery Devices Market From 2025 To 2029?

The market for intranasal drug delivery systems is anticipated to expand due to the rising incidence of long-term health conditions, which are characterized as ailments persisting for twelve months or longer, necessitating continuous medical management, restricting everyday functioning, or both.These specialized delivery tools offer a convenient, entirely non-invasive, and highly effective method for administering treatments associated with these enduring conditions, facilitating direct application to the target site, which promotes swift uptake.To illustrate this trend, official data from the UK’s National Health Service in June 2024 indicated that in 2023, the NHS registered an additional 549,000 people in England facing the probability of developing type 2 diabetes, elevating the count of individuals diagnosed with pre-diabetes, or non-diabetic hyperglycemia, under general practitioner care to 3,615,330, a notable jump from the 3,065,825 recorded in 2022, signifying an escalation close to 20%, clearly demonstrating how the surge in chronic ailments fuels the progression of the intranasal medication delivery technology sector.

What Are The Major Segment Types Covered In The Intranasal Drug Delivery Devices Market?

The intranasal drug delivery devicesmarket covered in this report is segmented –

1) By Product: Powder Delivery Device, Liquid Delivery Device, Pressurized Metered-Dose Inhalers, Other Products

2) By Dosage: Unit-Dose, Multi-Dose

3) By Application: Chronic Obstructive Pulmonary Disease (COPD), Rhinitis, Cystic Fibrosis, Nasal Congestion, Asthma, Other Applications

4) By End User: Hospitals, Clinics, Homecare, Other End Users

Subsegments:

1) By Powder Delivery Device: Single-Dose Powder Device, Multi-Dose Powder Device

2) By Liquid Delivery Device: Single-Dose Liquid Device, Multi-Dose Liquid Device

3) By Pressurized Metered-Dose Inhalers (pMDIs): Breath-Actuated PMDIs, Conventional pMDIs

4) By Other Products: Gel Delivery Device, Nebulizers, Nasal Sprays

Which Trends Are Impacting The Intranasal Drug Delivery Devices Market?

To maintain their standing within the nasal drug delivery technology sector, significant pharmaceutical entities are focused on innovating and refining offerings, presenting novel avenues for drug administration to their clientele. As an illustration, in the opening month of 2023, AptarGroup, Inc., a pharmaceutical and drug delivery firm situated in the United States, introduced APF Futurity, which is notable as the inaugural recyclable, metal-free, multidose nasal spray designed for administering nasal saline and comparable over-the-counter substances. Constructed wholly from polyolefin substances, APF Futurity completely bypasses the inclusion of metallic elements or any contaminants that hinder the recycling process, thereby facilitating easier sorting for recycling and encouraging a higher proportion of reused materials. A defining characteristic of this device is its fundamentally recyclable construction; this nasal spray pump enjoys the distinction of achieving Class AA certification from cyclos-HTP, confirming its compatibility with European recycling infrastructures.

Which Global Market Leaders Are Shaping The Future Of The Intranasal Drug Delivery Devices Sector?

Major companies operating in the intranasal drug delivery devices market report are Johnson and Johnson Inc., Merck and Co.Inc., Novartis AG, AstraZeneca plc., GlaxoSmithKline PLC, 3M Company, Becton, Dickinson and Company, Teva Pharmaceutical Industries Ltd., AptarGroup Inc., West Pharmaceutical Services Inc., Teleflex Incorporated, Recipharm AB, Nemera Development S.A., Consort Medical plc., Vectura Group PLC, Douglas Pharmaceuticals Ltd., Avanir Pharmaceuticals, OptiNoset Inc., Flamel Technologies, Aegis Therapeutics LLC, Sonoma Pharmaceuticals, PendoPharm Inc., Kurve Technology Inc., Impel NeuroPharma, Impexium Medical Products, B.F. Ascher and Company Inc., ENT Technologies Pty. Ltd., Neurelis Inc., Generex Biotechnology Corporation

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/intranasal-drug-delivery-devices-global-market-report

How Does The Intranasal Drug Delivery Devices Market Perform Across Key Geographic Regions?

North America was the largest region in the intranasal drug delivery devices market in 2024. The regions covered in the intranasal drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Intranasal Drug Delivery Devices Market Report:

https://www.thebusinessresearchcompany.com/customise?id=13463&type=smp

Browse Through More Reports Similar to the Global Intranasal Drug Delivery Devices Market 2025, By The Business Research Company

Electrophysiology Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/electrophysiology-devices-and-equipment-global-market-report

Electrosurgical Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/electrosurgical-devices-and-equipment-global-market-report

Ent Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ent-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795